DCF — BRISTOL REGIONAL MEDICAL CENTER
Enterprise Value: $38.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$38.8M
Enterprise Value
$3.8M
PV of Cash Flows
$35.0M
PV of Terminal Value
$56.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $302.7M | $11.1M | 4.0% | $-2.6M | $-2.3M |
| Year 2 | $311.8M | $14.6M | 5.0% | $-0.3M | $-0.3M |
| Year 3 | $321.2M | $18.2M | 6.0% | $2.1M | $1.6M |
| Year 4 | $330.8M | $20.4M | 6.0% | $3.4M | $2.3M |
| Year 5 | $340.7M | $21.9M | 6.0% | $4.1M | $2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $38.8M. Terminal value accounts for 90% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$293.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.031729924592996714
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5